|
HY-110287-50mg
|
MedChemexpress LLC
|
Apcin [CAS 300815-04-7]
|
|
Cancer-programmed cell death
|
|
|
HY-116572A-10mg
|
MedChemexpress LLC
|
TASIN-1 [CAS 792927-06-1]
|
|
Cancer-programmed cell death
|
|
|
HY-116572A-100mg
|
MedChemexpress LLC
|
TASIN-1 [CAS 792927-06-1]
|
|
Cancer-programmed cell death
|
|
|
HY-116572A-25mg
|
MedChemexpress LLC
|
TASIN-1 [CAS 792927-06-1]
|
|
Cancer-programmed cell death
|
|
|
HY-116572A-5mg
|
MedChemexpress LLC
|
TASIN-1 [CAS 792927-06-1]
|
|
Cancer-programmed cell death
|
|
|
HY-116572A-50mg
|
MedChemexpress LLC
|
TASIN-1 [CAS 792927-06-1]
|
|
Cancer-programmed cell death
|
|
|
HY-117930-1mg
|
MedChemexpress LLC
|
Danicopan [CAS 1903768-17-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-117930-10mg
|
MedChemexpress LLC
|
Danicopan [CAS 1903768-17-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-117930-100mg
|
MedChemexpress LLC
|
Danicopan [CAS 1903768-17-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-117930-25mg
|
MedChemexpress LLC
|
Danicopan [CAS 1903768-17-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-117930-5mg
|
MedChemexpress LLC
|
Danicopan [CAS 1903768-17-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-117930-50mg
|
MedChemexpress LLC
|
Danicopan [CAS 1903768-17-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-124955-1mg
|
MedChemexpress LLC
|
proTAME [CAS 1362911-19-0]
|
|
Cancer-Kinase/protease
|
|
|
HY-124955-10mg
|
MedChemexpress LLC
|
proTAME [CAS 1362911-19-0]
|
|
Cancer-Kinase/protease
|
|
|
HY-124955-100mg
|
MedChemexpress LLC
|
proTAME [CAS 1362911-19-0]
|
|
Cancer-Kinase/protease
|
|
|
HY-124955-25mg
|
MedChemexpress LLC
|
proTAME [CAS 1362911-19-0]
|
|
Cancer-Kinase/protease
|
|
|
HY-124955-5mg
|
MedChemexpress LLC
|
proTAME [CAS 1362911-19-0]
|
|
Cancer-Kinase/protease
|
|
|
HY-124955-50mg
|
MedChemexpress LLC
|
proTAME [CAS 1362911-19-0]
|
|
Cancer-Kinase/protease
|
|
|
HY-130841-10mg
|
MedChemexpress LLC
|
Apcin-A [CAS 1683617-62-0]
|
|
Cancer-programmed cell death
|
|
|
HY-130841-100mg
|
MedChemexpress LLC
|
Apcin-A [CAS 1683617-62-0]
|
|
Cancer-programmed cell death
|
|
|
HY-130841-25mg
|
MedChemexpress LLC
|
Apcin-A [CAS 1683617-62-0]
|
|
Cancer-programmed cell death
|
|
|
HY-130841-5mg
|
MedChemexpress LLC
|
Apcin-A [CAS 1683617-62-0]
|
|
Cancer-programmed cell death
|
|
|
HY-130841-50mg
|
MedChemexpress LLC
|
Apcin-A [CAS 1683617-62-0]
|
|
Cancer-programmed cell death
|
|
|
HY-13255-100mg
|
MedChemexpress LLC
|
TAME [CAS 901-47-3]
|
|
Cancer-programmed cell death
|
|
|
HY-13255-50mg
|
MedChemexpress LLC
|
TAME [CAS 901-47-3]
|
|
Cancer-programmed cell death
|
|
